Proteomics can be defined as the study of
proteomes. Proteomes are a set of proteins which are produced in a
system, organism, or any biological context. Proteomes vary from cell to
cell and changes over a period of time. Proteomics is used in various
applications, such as, to investigate protein expression, in
transcriptional and post transcriptional studies, metabolic pathways, to
study protein interaction in diseases viz. cancer, to study
localization of sub cellular proteins, etc. Proteomics can be studied
using various technologies, such as, mass spectrometry, gel-based
techniques, and others.
Report Overview @ https://www.transparencymarketresearch.com/global-proteomics-market.html
The global proteomics market is expected
to grow at a significant CAGR during the forecast period. Increasing
research & development activities in the healthcare industries,
rising demand for personalized medicines, and increasing activities of
drug discovery are some of the important factors expected to contribute
to the growth of the global proteomics market during the forecast
period. Rise in use of proteomics to study cancer genes and protein
interaction in cancer genes is projected to drive the growth of the
global proteomics market due to high prevalence of cancer across the
world. Factors such as application of proteomics in the diagnosis of
infectious diseases, technological advancement, increase in health care
expenditure, rise in awareness, etc. are the other factors likely to
boost the growth of the global proteomics market during the forecast
period. However, inadequate funding and lack of awareness regarding the
application of proteomics in developing countries are anticipated to
restrain the growth of global proteomics market during the forecast
period.
The global proteomics market can be
segmented on the basis of product, services, application, and region.
Based on product, the global proteomics market can be divided into
instrumentation and reagents. The instrumentation segment can be further
classified into spectrometry, chromatography, X-ray, immunoassay,
electrophoresis, and others. In terms of services, the global market can
be segmented into analytical laboratory services, sequencing, protein
identification, bioinformatics, and others. The anatomical laboratory
services segment is expected to hold a significant share of the market
during the forecast period due to effectiveness of services provided by
anatomical laboratories in diagnosis and drug discovery. On the basis of
application, the global proteomics market can be categorized into
clinical diagnosis, drug discovery, and others. The clinical diagnosis
segment is expected to hold a significant share of the market during the
forecast period due to rise in prevalence of cancer, increase in
incidence of infectious diseases, etc. across the globe.
The global proteomics market is expected
to grow at significant rate in all geographical regions. Based on
region, the global market can be segmented into North America, Europe,
Asia Pacific, Middle East & Africa, and Latin America. North America
is expected to dominate the global proteomics market throughout the
forecast period. Factors influencing the growth of market in North
America include rise in funding from government, increase in research
activities, high awareness regarding applications of proteomics,
improved health care infrastructure, high health care expenditure, and
rise in prevalence of cancer in the region. Europe is projected to be
the second leading market for proteomics during the forecast period due
to increase in cancer research activities, high funding from the
government, and presence of key market players in the region. Driver The
proteomics market in Asia Pacific is estimated to expand at a
significantly high CAGR during the forecast period. Growth drivers of
the proteomics market in the region include high prevalence of cancer,
rising health care expenditure, presence of a large number of drug
manufactures in countries such as India and Japan leading to increase in
drug discovery, and high prevalence of infectious diseases in the
region.
In order to maintain a significant
position in the global proteomics market, key players are adopting
strategies, such as, mergers & acquisitions, geographical expansion,
research & development, etc. Leading players operating in the
global proteomics market include GE Healthcare, Bio-Rad Laboratories,
Inc., Danaher Corporation, and PerkinElmer, Inc.
No comments:
Post a Comment